Project Rapid presents a unique opportunity to acquire a high-growth Australian medical technology business specialising in the manufacture of portable, affordable automated external defibrillators (AEDs).  The company’s flagship AED product is ultra-lightweight (under 300 grams), 50-60% cheaper, and up to 80 % smaller than traditional devices – designed for intuitive use by untrained individuals.

Since launch, over 26,000 units have been sold across Australia, Europe, and Asia (2022-H1 2025), generating ~USD 7.5 million in FY 2024 revenue.  With a Device-as-a-Service (DaaS) model, the company benefits from both upfront sales and recurring subscription revenue.  Devices are single-use with minimal maintenance requirements, enabled by proprietary IoMT self-checking technology.

Project Rapid targets a USD 7.4 billion addressable market, aiming to unlock household AED ownership by overcoming cost and design barriers.  The business is backed by a robust IP portfolio, with 127 active patents across 50 countries.

The company is currently undergoing a formal restructuring process.  This is a full sale transaction.  Currency tenders are to be submitted in USD only.  Initial expressions of interest are invited as soon as possible.

Opportunity Decks are available for interested parties by contacting Jovan Singh Partner of Hall Chadwick on +61 2 9263 2600 or via email jsingh@hallchadwick.com.au or Craig Nettelbeck, Corporate Advisor on +61 2 9263 2600 or via email cnettelbeck@hallchadwick.com.au.